Evidence map›Paper›PMID 29938576›Full record

ArticleAutophagy2018

Carbon nanotubes, but not spherical nanoparticles, block autophagy by a shape-related targeting of lysosomes in murine macrophages.

Vanessa Cohignac, Marion Julie Landry, Audrey Ridoux, Mathieu Pinault, Balasubramanyam Annangi, Adèle Gerdil, Nathalie Herlin-Boime, Martine Mayne, Masatake Haruta, Patrice Codogno and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Immunotoxicity of Carbon-Based Nanomaterials, Starring Phagocytes.International journal of molecular sciences · 2022
    Review
  10. Challenges in Nanomaterial Characterization - From Definition to Analysis.Advances in experimental medicine and biology · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Vanessa Cohignaca Inserm U955, Institut Mondor de Recherche Biomédicale (IMRB) Equipe 04 , Créteil , France.
Marion Julie Landrya Inserm U955, Institut Mondor de Recherche Biomédicale (IMRB) Equipe 04 , Créteil , France.
Audrey Ridouxa Inserm U955, Institut Mondor de Recherche Biomédicale (IMRB) Equipe 04 , Créteil , France.
Mathieu Pinaultc NIMBE, CEA, CNRS, Université Paris-Saclay, CEA Saclay , Gif sur Yvette Cedex , France.
Balasubramanyam Annangia Inserm U955, Institut Mondor de Recherche Biomédicale (IMRB) Equipe 04 , Créteil , France.ORCID 0000-0002-1479-138X
Adèle Gerdilc NIMBE, CEA, CNRS, Université Paris-Saclay, CEA Saclay , Gif sur Yvette Cedex , France.
Nathalie Herlin-Boimec NIMBE, CEA, CNRS, Université Paris-Saclay, CEA Saclay , Gif sur Yvette Cedex , France.
Martine Maynec NIMBE, CEA, CNRS, Université Paris-Saclay, CEA Saclay , Gif sur Yvette Cedex , France.
Masatake Harutad Research Center for Gold 1-1 Minami Osawa Hachioji , Tokyo Metropolitan University , Tokyo , Japan.
Patrice Codognoe Inserm U1151 CNRS UMR 8253, Institut Necker-Enfants Malades (INEM) , Paris , France.ORCID 0000-0002-5492-3180
Jorge Boczkowskia Inserm U955, Institut Mondor de Recherche Biomédicale (IMRB) Equipe 04 , Créteil , France.ORCID 0000-0001-6619-5785
Jean-Claude Pairona Inserm U955, Institut Mondor de Recherche Biomédicale (IMRB) Equipe 04 , Créteil , France.
Sophie Lanonea Inserm U955, Institut Mondor de Recherche Biomédicale (IMRB) Equipe 04 , Créteil , France.ORCID 0000-0003-2509-8799
Inserm · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRTokyo Metropolitan University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs) can be toxic, depending on their physico-chemical characteristics. Macroautophagy/autophagy could represent a potential underlying mechanism of this toxicity. We therefore set up a study aimed to characterize in depth the effects, on autophagy, of macrophage exposure to NPs, with a particular attention paid to the role of NP physico-chemical characteristics (specifically chemical composition, shape, size, length, crystal phase, and/or surface properties). We demonstrate that exposure to carbon nanotubes (CNT) but not to spherical NPs leads to the blockage of the autophagic flux. We further identified lysosomal dysfunction, in association with the downregulation of SNAPIN expression, as the underlying mechanism responsible for the CNT-induced autophagy blockade. These results identify for the first time the shape as a major determinant of the interaction of NPs with the autophagy pathway. Moreover, identifying the lysosomes and SNAPIN as primary targets of MWCNT toxicity opens new directions in the interpretation and understanding of nanomaterial toxicity.

Indexed as

AutophagyAnimalsBiomarkersEndocytosisLysosomal-Associated Membrane Protein 1LysosomesMacrophagesMiceMicrotubule-Associated ProteinsNanoparticlesNanotubes, CarbonRAW 264.7 CellsTitaniumVesicular Transport ProteinsBiomarkersLysosomal-Associated Membrane Protein 1Map1lc3b protein, mouseMicrotubule-Associated ProteinsNanotubes, CarbonSnapin protein, mouseTitaniumtitanium dioxideVesicular Transport ProteinsAutophagycarbon nanotubeslysosomesphysico-chemical characteristicstitanium dioxide

Identifiers

PMID29938576
PMCPMC6103705
OpenAlexW2809750823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.